Fairvalue-Calculator Fairvalue-Calculator
EN DE

Frontage Holdings (FGHQF) Fair Value & Analysis

Healthcare · US · Market cap $223M

Price$0.1400
Fair Value$0.0700
Upside-50.0%
Quality94/100
Evidence: High Range $0.0500 – $0.0900

Fair value as of: Jun 26, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Frontage Holdings (FGHQF) currently trades at $0.1400, while our model-based Fair Value estimate is $0.0700 — implying the stock looks roughly 50.0% overvalued today. We read business quality at 94/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Frontage Holdings Corporation provides drug discovery, drug development, pharmaceutical product development, and laboratory testing services to pharmaceutical, biotechnology, and agrochemical companies. It offers drug discovery services comprising medicinal chemistry, pharmacology, and efficacy, as well as absorption, distribution, metabolism, and excretion (ADME) screening. The company also provides drug metabolism and pharmacokinetics (DMPK); safety and toxicology; early phase clinical services; and bioequivalence and related services, such as pharmacology, medical writing, and regulatory support. In addition, it offers pharmaceutical product development services, including intermediate and active pharmaceutical ingredient (API) synthesis, process and formulation development, and clinical trial material manufacturing. Further, the company provides laboratory testing services, such as bioanalysis, biomarkers, genomics, chemistry, manufacturing and controls ("CMC") analytical testin…

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -32% Regeneron Pharmaceuticals, Inc (REGN) -4% UCB SA (UCB) -23% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +1% Alnylam Pharmaceuticals, Inc (ALNY) -82%

Frequently asked questions

Is Frontage Holdings (FGHQF) undervalued?
As of Jun 26, 2026, our model estimates a fair value of $0.0700 versus a price of $0.1400 — about −50% (overvalued). Model-based estimate, not financial advice.
What is the fair value of FGHQF?
Our 21-model fair value for Frontage Holdings is $0.0700 (as of Jun 26, 2026), built from audited fundamentals. The current price is $0.1400.
What is the quality score of FGHQF?
Frontage Holdings has a Quality Score of 94/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.